DE3486409T2 - Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. - Google Patents

Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.

Info

Publication number
DE3486409T2
DE3486409T2 DE3486409T DE3486409T DE3486409T2 DE 3486409 T2 DE3486409 T2 DE 3486409T2 DE 3486409 T DE3486409 T DE 3486409T DE 3486409 T DE3486409 T DE 3486409T DE 3486409 T2 DE3486409 T2 DE 3486409T2
Authority
DE
Germany
Prior art keywords
composition
active ingredient
controlled release
release
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3486409T
Other languages
English (en)
Other versions
DE3486409D1 (de
Inventor
Richard William Baker
James William Brooke
Kelly Lincoln Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8192120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3486409(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE3486409D1 publication Critical patent/DE3486409D1/de
Publication of DE3486409T2 publication Critical patent/DE3486409T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DE3486409T 1984-08-17 1984-08-17 Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. Expired - Lifetime DE3486409T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP84109832A EP0171457B1 (de) 1984-08-17 1984-08-17 Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffes und ihre Herstellung

Publications (2)

Publication Number Publication Date
DE3486409D1 DE3486409D1 (de) 1995-11-16
DE3486409T2 true DE3486409T2 (de) 1996-04-25

Family

ID=8192120

Family Applications (3)

Application Number Title Priority Date Filing Date
DE8484109832T Expired - Fee Related DE3485618D1 (de) 1984-08-17 1984-08-17 Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und ihre herstellung.
DE3486409T Expired - Lifetime DE3486409T2 (de) 1984-08-17 1984-08-17 Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
DE2000175031 Active DE10075031I2 (de) 1984-08-17 1984-08-17 Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8484109832T Expired - Fee Related DE3485618D1 (de) 1984-08-17 1984-08-17 Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und ihre herstellung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2000175031 Active DE10075031I2 (de) 1984-08-17 1984-08-17 Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.

Country Status (4)

Country Link
EP (2) EP0171457B1 (de)
CA (2) CA1239034A (de)
DE (3) DE3485618D1 (de)
NL (1) NL300007I2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331338C (en) * 1987-02-03 1994-08-09 Dow Corning Corporation Aqueous film-forming compositions for controlling the release of active agents and process of making same
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
GB8717168D0 (en) 1987-07-21 1987-08-26 Roussel Lab Ltd Controlled-release device
IE60383B1 (en) * 1988-05-27 1994-07-13 Elan Corp Plc Controlled release pharmaceutical formulation
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5078888A (en) * 1989-04-06 1992-01-07 Dow Corning Corporation Method for processing aqueous fermentation broths
US5024937A (en) * 1989-04-06 1991-06-18 Dow Corning Corporation Method for processing aqueous fermentation broths
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
GB9217295D0 (en) * 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
EP0670717B1 (de) * 1992-11-30 1998-11-25 Pfizer Inc. Verabreichungsvorrichtungen mit gestützten flüssigen membranen
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5541231A (en) * 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
CA2318921A1 (en) 1998-01-29 1999-08-05 John R. Mccullough Pharmacological uses of optically pure (+)-bupropion
US6110973A (en) * 1998-01-29 2000-08-29 Sepracor Methods for treating obesity and weight gain using optically pure (-)-bupropion
US6033686A (en) * 1998-10-30 2000-03-07 Pharma Pass Llc Controlled release tablet of bupropion hydrochloride
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6342496B1 (en) 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
TR200300731T2 (tr) 2000-11-28 2004-08-23 Fmc Corporation Yenebilir PGA kaplama bileşimi
US8586085B2 (en) 2004-11-08 2013-11-19 Biokey, Inc. Methods and formulations for making pharmaceutical compositions containing bupropion
KR100670798B1 (ko) 2004-12-17 2007-01-17 한국전자통신연구원 데이터베이스 캐시 시스템

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2011587A (en) * 1934-03-24 1935-08-20 Kelp Ol Lab Inc Coating for medical compound
US2602040A (en) * 1949-06-28 1952-07-01 Givaudan Corp Enteric coated sympatholytic composition
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
SE324859B (de) * 1967-09-04 1970-06-15 Ercopharm As
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
US4425363A (en) * 1981-05-14 1984-01-10 Burroughs Wellcome Co. Treatment of tardive dyskinesia in mammals
US4428926A (en) * 1981-12-18 1984-01-31 Key Pharmaceuticals, Inc. Sustained release propranolol system
JPS58134019A (ja) * 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
EP0159604B1 (de) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Präparat mit verzögerter Freigabe zum Aufbringen auf die Schleimhäute der Mundhöhle

Also Published As

Publication number Publication date
DE3485618D1 (de) 1992-04-30
EP0171457A1 (de) 1986-02-19
NL300007I1 (nl) 2000-08-01
CA1239034A (en) 1988-07-12
CA1321754B (en) 1993-08-31
EP0171457B1 (de) 1992-03-25
NL300007I2 (nl) 2001-03-01
EP0467488A3 (en) 1992-04-15
DE3486409D1 (de) 1995-11-16
EP0467488A2 (de) 1992-01-22
DE10075031I1 (de) 2001-01-18
EP0467488B1 (de) 1995-10-11
DE10075031I2 (de) 2004-07-01

Similar Documents

Publication Publication Date Title
DE3486409T2 (de) Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
ES263908Y (es) "bloque perfeccionado para la construccion de edificios".
MX10621A (es) Compuestos de piperazinil heterociclicos y procedimiento para su preparacion.
DE3880047T2 (de) Zusammensetzung eines zusatzes.
ES514750A0 (es) "procedimiento para la preparacion de n-fenil-sulfonil-n'-pirimidinil- y -triacinil-ureas".
ES516648A0 (es) "procedimiento para la preparacion de n-(2-piridiloxifenil)-n-benzoilureas substituidas".
ES539822A0 (es) Procedimiento para la preparacion de pirazolopiridinas.
ES512045A0 (es) "procedimiento de preparar compuestos benzoxepinicos y analogos".
ES515453A0 (es) "procedimiento para la preparacion de esteres perfluoroalcohilicos".
IT8124141A0 (it) Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina.
IT8521570A0 (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti.
ES514505A0 (es) "procedimiento para la preparacion de 1-amino-4-hidroxi-antraquinonas".
ES508293A0 (es) "procedimiento para la preparacion de derivados de tiazolina".
ES514274A0 (es) "procedimiento para la preparacion de benzotriazoles".
ES514394A0 (es) "procedimiento para la preparacion de metil terci-butileter o etilterci-butileter".
ES512949A0 (es) "procedimiento para la preparacion de imidazolil-propionitrilos".
ES514106A0 (es) "procedimiento para la preparacion de hidrazonocefem-derivados".
ES511252A0 (es) "procedimiento para la preparacion de prostaglandinas".
ES513956A0 (es) "procedimiento para la carbonilacion de olefinas y esteres organicos".
ES512415A0 (es) "procedimiento para la preparacion de derivados de xilita".
ES516225A0 (es) "procedimiento para la preparacion de derivados de bis-aminometil-antraquinona".
ES510945A0 (es) "procedimiento para la preparacion de amino-pridinas".
ES508961A0 (es) "procedimiento para la preparacion de imidazolil-vinil-eteres".
ATE45087T1 (de) Dosiseinheiten zur gesteuerten freigabe einer wirksubstanz.
MX10058A (es) Composicion herbicida y procedimiento para su preparacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: BUPROPION HYDROCHLORID (=AMFEBUTAMENHYDROCHLORID); REGISTRATION NO/DATE: 49008.00.00, 20000628

Spc suppl protection certif: 100 75 031

Filing date: 20001020

8327 Change in the person/name/address of the patent owner

Owner name: THE WELLCOME FOUNDATION LTD., GREENFORD, MIDDLESEX

V457 Spc granted

Free format text: PRODUCT NAME: BUPROPION HYDROCHLORID (=AMFEBUTAMENHYDROCHLORID); REGISTRATION NO/DATE: 49008.00.00, 20000628

Spc suppl protection certif: 100 75 031

Filing date: 20001020

V464 Spc expired

Free format text: PRODUCT NAME: BUPROPION HYDROCHLORID (=AMFEBUTAMENHYDROCHLORID); REGISTRATION NO/DATE: 49008.00.00, 20000628

Spc suppl protection certif: 100 75 031

Filing date: 20001020